Small Antibodies with Big Applications: Nanobody-Based Cancer Diagnostics and Therapeutics
Cancers · 29.11.2023 · 15 (23) · 5639
DOI: 10.3390/cancers15235639 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 29.11.2023. Verfasst von Qian Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Joint Laboratory of Guangdong-Hong Kong Universities for Vascular Homeostasis and Diseases, School of Medicine, Southern …. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 138 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Monoclonal antibodies (mAbs) have exhibited substantial potential as targeted therapeutics in cancer treatment due to their precise antigen-binding specificity. Despite their success in tumor-targeted therapies, their effectiveness is hindered by their large size and limited tissue permeability. Camelid-derived single-domain antibodies, also known as nanobodies, represent the smallest naturally occurring antibody fragments. Nanobodies offer distinct advantages over traditional mAbs, including their smaller size, high stability, lower manufacturing costs, and deeper tissue penetration capabilities. They have demonstrated significant roles as both diagnostic and therapeutic tools in cancer research and are also considered as the next generation of antibody drugs. In this review, our objective is to provide readers with insights into the development and various applications of nanobodies in the field of cancer treatment, along with an exploration of the challenges and strategies for their prospective clinical trials.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacology, Joint Laboratory of Guangdong-Hong Kong Universities for Vascular Homeostasis and Diseases, School of Medicine, Southern University of Science and Technology, Shenzhen 518055, China.
- School of Biomedical Engineering, Guangzhou Medical University, Guangzhou 511436, China.
- Cuiying Biomedical Research Center, Lanzhou University Second Hospital, Lanzhou 730030, China.
ORCID-Profile: Qian Zhang, Chen Wang
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Zhang, Q., Zhang, N., Xiao, H., Wang, C., & He, L. (2023). Small Antibodies with Big Applications: Nanobody-Based Cancer Diagnostics and Therapeutics. Cancers, 15(23), 5639. https://doi.org/10.3390/cancers15235639
Vancouver
Zhang Q, Zhang N, Xiao H, Wang C, He L. Small Antibodies with Big Applications: Nanobody-Based Cancer Diagnostics and Therapeutics. Cancers. 2023;15(23):5639. doi:10.3390/cancers15235639
BibTeX
@article{Zhang2023,
author = {Zhang, Qian and Zhang, Nan and Xiao, Han and Wang, Chen and He, Lian},
title = {Small Antibodies with Big Applications: Nanobody-Based Cancer Diagnostics and Therapeutics},
journal = {Cancers},
year = {2023},
volume = {15},
number = {23},
pages = {5639},
doi = {10.3390/cancers15235639}
}
EUVIMED